Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02961374
Title Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic in Arizona Scottsdale Arizona 85259 United States Details
University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109 United States Details
Mayo Clinic in Rochester Rochester Minnesota 55905 United States Details
Cleveland Clinic Foundation Cleveland Ohio 44195 United States Details
University of Pittsburgh Cancer Institute (UPCI) Pittsburgh Pennsylvania 15232 United States Details
M D Anderson Cancer Center Houston Texas 77030 United States Details
Huntsman Cancer Institute/University of Utah Salt Lake City Utah 84112 United States Details
University of Puerto Rico San Juan 00936 Puerto Rico Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field